Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects

University of Toronto

$144,125.00

A tissue engineering platform to identify target combinations in tumour stoma to render tumours therapy sensitive

FY 2017-18

Summary
Survival rates for many cancer types are poor and there is a need for new therapies to be developed. A major challengefaced by drug companies is identifying the most promising drugs that will be effective in patients. Currently new drugs aretested on cells cultured in 2D plastic dishes. Studies using this approach however, do not accurately predict how well thedrug will work in patients. One reason contributing to the poor predictability of 2D dishes is that the environment is verydifferent from that in a real tumor in a patient and cell properties (and how they respond to a drug) are strongly dependent ontheir local environment. A need exists for models that better recapitulate the tumor environment and allow an accurateassessment of new drug to ensure the most promising therapies reach patients faster. We have developed a strategy toengineer artificial tumours in which such analysis is possible. Here we will assess the benefits of our new approachcompared to standard 2D dishes and then use our platform to test the effectiveness of new drugs to treat head and neckcancer.
Program
Collaborative Health Research Projects
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
493719-2016
Name nom
McGuigan, Alison
Department département
Chemical Engineering and Applied Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
144125
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Partie
2 & 3
Nb partie
3
Application title
A tissue engineering platform to identify target combinations in tumour stoma to render tumours therapy sensitive
Keyword
NSERC
Application summary
Survival rates for many cancer types are poor and there is a need for new therapies to be developed. A major challengefaced by drug companies is identifying the most promising drugs that will be effective in patients. Currently new drugs aretested on cells cultured in 2D plastic dishes. Studies using this approach however, do not accurately predict how well thedrug will work in patients. One reason contributing to the poor predictability of 2D dishes is that the environment is verydifferent from that in a real tumor in a patient and cell properties (and how they respond to a drug) are strongly dependent ontheir local environment. A need exists for models that better recapitulate the tumor environment and allow an accurateassessment of new drug to ensure the most promising therapies reach patients faster. We have developed a strategy toengineer artificial tumours in which such analysis is possible. Here we will assess the benefits of our new approachcompared to standard 2D dishes and then use our platform to test the effectiveness of new drugs to treat head and neckcancer.
University of Toronto - $144,125 Grant (2017-18) | Canada Spends